Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.

Yang J, Ouyang J, Ouyang L, Ouyang L, Chen Y.

Oncol Res. 2013;21(1):43-50. doi: 10.3727/096504013X13793555706722.

PMID:
24330851
2.

Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.

Jiang C, Yi XP, Shen H, Li YX.

World J Gastroenterol. 2012 Jun 21;18(23):2956-65. doi: 10.3748/wjg.v18.i23.2956.

3.

Lentivirus-mediated shRNA targeting XIAP and survivin inhibit SW1990 pancreatic cancer cell proliferation in vitro and in vivo.

Jiang C, Tan T, Yi XP, Shen H, Li YX.

Mol Med Rep. 2011 Jul-Aug;4(4):667-74. doi: 10.3892/mmr.2011.472. Epub 2011 Apr 6.

PMID:
21479361
4.

[X-linked inhibitor of apoptosis protein (XIAP) and Survivin suppression on human pancreatic cancer cells Panc-1 proliferation and chemosensitivety].

Zai HY, Yi XP, Li YX, You XY, Cao LP, Liu H.

Beijing Da Xue Xue Bao. 2013 Apr 18;45(2):242-9. Chinese.

5.

Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway.

Yi XP, Han T, Li YX, Long XY, Li WZ.

Mol Med Rep. 2015 Jul;12(1):601-8. doi: 10.3892/mmr.2015.3380. Epub 2015 Feb 20.

PMID:
25707849
6.
7.

Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells.

Shrikhande SV, Kleeff J, Kayed H, Keleg S, Reiser C, Giese T, Büchler MW, Esposito I, Friess H.

Anticancer Res. 2006 Sep-Oct;26(5A):3265-73.

8.
9.

Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.

Wang ZH, Chen H, Guo HC, Tong HF, Liu JX, Wei WT, Tan W, Ni ZL, Liu HB, Lin SZ.

Int J Oncol. 2011 Nov;39(5):1123-31. doi: 10.3892/ijo.2011.1115. Epub 2011 Jul 6.

PMID:
21743963
10.

Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.

Guo HC, Bu HQ, Luo J, Wei WT, Liu DL, Chen H, Tong HF, Wang ZH, Wu HY, Li HH, Zuo MM, Li W, Lin SZ.

Int J Oncol. 2012 Jun;40(6):1849-57. doi: 10.3892/ijo.2012.1389. Epub 2012 Feb 29.

PMID:
22378302
11.

Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.

Galloway NR, Aspe JR, Sellers C, Wall NR.

Pancreas. 2009 Oct;38(7):782-90. doi: 10.1097/MPA.0b013e3181a85999.

12.

Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.

Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.

Cancer Res. 2008 Oct 1;68(19):7956-65. doi: 10.1158/0008-5472.CAN-08-1296.

13.

siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.

Liu WS, Yan HJ, Qin RY, Tian R, Wang M, Jiang JX, Shen M, Shi CJ.

Dig Dis Sci. 2009 Jan;54(1):89-96. doi: 10.1007/s10620-008-0329-4. Epub 2008 Jul 2.

PMID:
18594980
14.
15.

Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

Karikari CA, Roy I, Tryggestad E, Feldmann G, Pinilla C, Welsh K, Reed JC, Armour EP, Wong J, Herman J, Rakheja D, Maitra A.

Mol Cancer Ther. 2007 Mar;6(3):957-66. Epub 2007 Mar 5.

16.

RNA interference‑mediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro.

Song J, Cao L, Li Y.

Mol Med Rep. 2013 May;7(5):1651-5. doi: 10.3892/mmr.2013.1361. Epub 2013 Mar 6.

PMID:
23467576
17.

A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells.

Kawanami T, Takiguchi S, Ikeda N, Funakoshi A.

Oncol Rep. 2012 Mar;27(3):867-72. doi: 10.3892/or.2011.1597. Epub 2011 Dec 20.

PMID:
22200743
18.

Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine.

Cao LP, Song JL, Yi XP, Li YX.

Oncol Rep. 2013 Apr;29(4):1659-65. doi: 10.3892/or.2013.2246. Epub 2013 Jan 23.

PMID:
23354694
19.

Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.

Singla S, Pippin JA, Drebin JA.

Oncol Rep. 2012 Dec;28(6):2211-6. doi: 10.3892/or.2012.2053. Epub 2012 Sep 24.

PMID:
23007710
20.

[Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].

Cheng ZY, Wan JS, Wang YL, Liang LQ, Liang WT, Mu J, Lu X, Pan L.

Zhonghua Yi Xue Za Zhi. 2011 Nov 1;91(40):2868-72. Chinese.

PMID:
22333553
Items per page

Supplemental Content

Write to the Help Desk